Inotuzumab ozogamicin: Difference between revisions

Jump to navigation Jump to search
m (Protected "Inotuzumab ozogamicin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 26: Line 26:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


==Overview==
==Overview==
Line 33: Line 33:


{{humanizedmonoclonals}}
{{humanizedmonoclonals}}
{{SIB}}
 
[[Category:Monoclonal antibodies]]
[[Category:Monoclonal antibodies]]
[[Category:Cancer treatments]]
[[Category:Cancer treatments]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 16:25, 9 August 2012

Template:Drugbox-mab

WikiDoc Resources for Inotuzumab ozogamicin

Articles

Most recent articles on Inotuzumab ozogamicin

Most cited articles on Inotuzumab ozogamicin

Review articles on Inotuzumab ozogamicin

Articles on Inotuzumab ozogamicin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Inotuzumab ozogamicin

Images of Inotuzumab ozogamicin

Photos of Inotuzumab ozogamicin

Podcasts & MP3s on Inotuzumab ozogamicin

Videos on Inotuzumab ozogamicin

Evidence Based Medicine

Cochrane Collaboration on Inotuzumab ozogamicin

Bandolier on Inotuzumab ozogamicin

TRIP on Inotuzumab ozogamicin

Clinical Trials

Ongoing Trials on Inotuzumab ozogamicin at Clinical Trials.gov

Trial results on Inotuzumab ozogamicin

Clinical Trials on Inotuzumab ozogamicin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Inotuzumab ozogamicin

NICE Guidance on Inotuzumab ozogamicin

NHS PRODIGY Guidance

FDA on Inotuzumab ozogamicin

CDC on Inotuzumab ozogamicin

Books

Books on Inotuzumab ozogamicin

News

Inotuzumab ozogamicin in the news

Be alerted to news on Inotuzumab ozogamicin

News trends on Inotuzumab ozogamicin

Commentary

Blogs on Inotuzumab ozogamicin

Definitions

Definitions of Inotuzumab ozogamicin

Patient Resources / Community

Patient resources on Inotuzumab ozogamicin

Discussion groups on Inotuzumab ozogamicin

Patient Handouts on Inotuzumab ozogamicin

Directions to Hospitals Treating Inotuzumab ozogamicin

Risk calculators and risk factors for Inotuzumab ozogamicin

Healthcare Provider Resources

Symptoms of Inotuzumab ozogamicin

Causes & Risk Factors for Inotuzumab ozogamicin

Diagnostic studies for Inotuzumab ozogamicin

Treatment of Inotuzumab ozogamicin

Continuing Medical Education (CME)

CME Programs on Inotuzumab ozogamicin

International

Inotuzumab ozogamicin en Espanol

Inotuzumab ozogamicin en Francais

Business

Inotuzumab ozogamicin in the Marketplace

Patents on Inotuzumab ozogamicin

Experimental / Informatics

List of terms related to Inotuzumab ozogamicin


Overview

Inotuzumab ozogamicin is a humanized monoclonal antibody and which is used to treat cancers. Inotuzumab has a chelator, ozogamicin, same as in gemtuzumab.


Template:Humanizedmonoclonals

Template:WikiDoc Sources